Chronic obstructive pulmonary disease (COPD) is the end result of a series of dynamic and cumulative gene-environment interactions over a lifetime…
An electronic nose can identify hospitalized ECOPD patients at risk of early readmission after discharge.
The addition of inhaled budesonide to usual care is safe and may reduce the risk of disease progression in patients hospitalised because of COVID-19 pneumonia
Recent guidelines consider chronic cough to be a unique clinical entity with different phenotypes. We aimed to investigate them in a general population and to describe prevalence, distribution, and characteristics of these phenotypes within the Austrian general population.
Entrevista a Alvar Agutí en periódico digital El Español, donde habla extensamente no sólo de su experiencia como profesional y experto en la EPOC, sino como paciente afectado del síndrome Guillaín-Barré, ingresado en su propio hospital, desde el que tuvo que volver a aprender a hablar, escribir, andar… con 60 años:
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary
A pair of review articles examines our current understanding of the biology, diagnosis, and treatment of chronic obstructive pulmonary disease. This article focuses on the pathogenesis of COPD.
